Skip to main content
SpringerLink
Log in
Book cover

Molecular Aspects of Anticancer Drug-DNA Interactions

  • Textbook
  • © 1993

Overview

Editors:
  1. Stephen Neidle

    1. Institute of Cancer Research, Sutton, Surrey, UK

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Michael J. Waring

    1. Department of Pharmacology, University of Cambridge, Cambridge, UK

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Topics in Molecular and Structural Biology (TMSB)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (11 chapters)

  1. Front Matter

    Pages i-xi
    Download chapter PDF

  2. Selectivity in Alkylating Agent-DNA Interactions

    • John A. Hartley
    Pages 1-31

  3. Structure-Activity Studies of Anthracycline-DNA Complexes

    • Andrew H.-J. Wang
    Pages 32-53

  4. Advances in the Study of Pyrrolo[2,1-c] [1,4]benzodiazepine (PBD) Antitumour Antibiotics

    • David E. Thurston
    Pages 54-88

  5. Molecular aspects of the interaction of (+)-CC-1065 with DNA

    • Laurence H. Hurley, Patricia H. Draves
    Pages 89-133

  6. Molecular Aspects of Platinum-DNA Interactions

    • Kenneth M. Comess, Stephen J. Lippard
    Pages 134-168

  7. New Platinum Drugs

    • Mark J. McKeage, Lloyd R. Kelland
    Pages 169-212

  8. Echinomycin and Related Quinoxaline Antibiotics

    • Michael J. Waring
    Pages 213-242

  9. Molecular Basis of Neocarzinostatin Action: Roles of DNA Microstructure and Thiol in the Mechanism of Bistranded Oxidative Damage

    • Irving H. Goldberg
    Pages 243-271

  10. Antisense Oligonucleotides as Potential Inhibitors of Gene Expression

    • David M. Tidd
    Pages 272-300

  11. Antigene Nucleic Acids — Inhibition of Gene Expression via Triple Helix Formation

    • David A. Collier
    Pages 301-321

  12. Design of Sequence-specific Agents: Lexitropsins

    • J. William Lown
    Pages 322-355

  13. Back Matter

    Pages 357-364
    Download chapter PDF
Back to top

Keywords

About this book

The Series provides researchers in the biological and medical sciences with timely reviews of selected areas in the molecular biology. Each volume is edited by an internationally recognised authority who selects authors and topics to provide a survey of current growth points in a specific field. Molecular Aspects of Anticancer Drug - DNA Interactions aims to be a definitive work in the cancer chemotherapy area replacing the editors previous book on anti-cancer drug design which though still widely quoted as the standard book in the field has now become rather out of date. Such is the wealth of important new material generated by the most prominent workers in the field that the Publishers have found it necessary to split the work text into two volumes. Volume two will be published later in the year.

Editors and Affiliations

  • Institute of Cancer Research, Sutton, Surrey, UK

    Stephen Neidle

  • Department of Pharmacology, University of Cambridge, Cambridge, UK

    Michael J. Waring

Bibliographic Information

  • Book Title: Molecular Aspects of Anticancer Drug-DNA Interactions

  • Editors: Stephen Neidle, Michael J. Waring

  • Series Title: Topics in Molecular and Structural Biology

  • DOI: https://doi.org/10.1007/978-1-349-12356-8

  • Publisher: Red Globe Press London

  • eBook Packages: Engineering, Engineering (R0)

  • Copyright Information: Macmillan Publishers Limited 1993

  • Edition Number: 1

  • Number of Pages: XI, 369

  • Additional Information: Previously published under the imprint Palgrave

  • Topics: Cell Biology

Publish with us

Policies and ethics

Back to top

Search

Navigation